NRG2 and gastric cancer: Nevertheless, GC cases with overexpression of ERBB2 and NRG2 (ERBB2-H/NRG2-H) were more sensitive to Lapatinib, compared to low gene expression of ERBB2-L/NRG2-L group (P = 0.042, Figure 4C, left).